⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2026Therapeutic Advances in Drug SafetyOpen Access

How is AI developing in pharmacovigilance?

Andrew Bate Philip Tregunno

View Full Paper

Ask AI

Bookmark

Share

Key Points

AI plays a crucial role in pharmacovigilance, improving detection of adverse events through data mining and predictive analytics.
The analysis shows a significant increase in adverse event reporting efficiency when utilizing artificial intelligence technologies.
Approach includes leveraging various data sources to enhance pharmacovigilance processes, emphasizing real-time safety monitoring.
This highlights the potential for AI to significantly improve drug safety protocols, needing further implementation studies.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Observational analysis reveals the role of AI in detecting adverse events, suggesting enhanced safety monitoring.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bate et al. (2026) studied this question.

synapsesocial.com/papers/69a75f4dc6e9836116a2a946 https://doi.org/10.1177/20420986251412773

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Editorial: Computational methods and systems to support decision making in pharmacovigilanceMeta-Analysis · 2023 · 4 citations
2Artificial Intelligence and Machine Learning for Safe MedicinesOriginal Research · 2022 · 23 citations
3Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping ReviewReview · 2022 · 84 citations
4Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 1—Overview of Knowledge Discovery Techniques in Artificial IntelligenceSystematic Review · 2020 · 29 citations
5Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language ProcessingOriginal Research · 2023 · 19 citations

More related papers

Text summarization with ChatGPT for drug labeling documents2024
Safety of medicines and vaccines – building next generation capability2021
BERT based natural language processing for triage of adverse drug reaction reports shows close to human-level performance2023

More from Therapeutic Advances in Drug Safety

Transient monocular vertical hemifield loss as a rare acute oxaliplatin-induced ophthalmological side effect: a case report and review of the literatureTue,
Evaluation of digoxin dosing and therapeutic drug monitoring in adult patients receiving continuous venovenous hemodiafiltrationTue,